MEDVi vs Zealthy: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher & Publisher
MEDVi beats Zealthy overall, scoring 7.7/10 vs 7.2/10. MEDVi is more affordable at $179/mo vs $286/mo. Choose MEDVi for users who want a low entry price with oral and injectable co. Choose Zealthy for insured users who want dedicated coordinators handling prior.
A side-by-side look at MEDVi and Zealthy to help you decide. We compare them on:
- •Starting price per month
- •Our overall score, out of 10
- •Medication type, brand-name or compounded
- •Whether they accept insurance
- •Who each one is best for
MEDVi
#18 of 53MEDVi is a compounded GLP-1 telehealth platform offering both oral tablets and injectable semaglutide and tirzepatide, with micro-dosing options for side-effect-sensitive patients. $179/mo entry pricing, free shipping, and a streamlined intake, one of the broader compounded mixes among independent telehealth providers in 2026.
Visit MEDViZealthy
#38 of 53Flexible GLP-1 provider allowing patients to switch between compounded and brand-name medications as needed.
Visit Zealthy| Feature | MEDVi | Zealthy |
|---|---|---|
| Why each one | The only compounded GLP-1 platform offering a structured oral-to-injectable transition pathway with micro-dosing options for side-effect-sensitive patients. | Dedicated insurance coordinators handle prior authorizations for brand-name GLP-1s, plus multi-month supply options up to 12 months. |
| Our Score | 7.7/10 | 7.2/10 |
| Starting Price | $179/mo | $286/mo |
| Medication Type | Both | Both |
| Insurance Accepted | No | No |
| Best For | Users who want a low entry price with oral and injectable compounded options | Insured users who want dedicated coordinators handling prior authorizations for brand-name GLP-1s (potentially $25/mo) |
| Watch out for | No brand-name Wegovy or Zepbound on the platform (the 2026 expansion added branded Ozempic only) | The $135 membership stacks on medication cost, so cash-pay semaglutide totals ~$286/mo, above average. The math works when you use the insurance coordination; cash payers should compare flat-rate platforms first. |
| Ranking | #18 | #38 |
| Get started | Visit MEDVi | Visit Zealthy |
Pros & Cons Compared
MEDVi
Pros
- +One of the few compounded providers offering both oral tablets and injectable semaglutide
- +Micro-dosing options available, can start at sub-standard doses for patients concerned about side effects
- +Sleek onboarding experience with clear progress tracking through their patient portal
- +$179/mo is competitive for a platform with both oral and injectable compounded formulations
Cons
- −No brand-name Wegovy or Zepbound on the platform (the 2026 expansion added branded Ozempic only)
- −No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms; you can switch to injectable anytime at no extra fee if results lag
Zealthy
Pros
- +Dedicated insurance coordinators handle prior authorizations, potentially bringing brand-name GLP-1 costs to $25/mo
- +Multi-month supply options (3, 6, or 12 months), unique convenience most monthly-shipping competitors can't match
- +Both compounded and brand-name (Wegovy, Zepbound) available with clinician-guided selection
- +LegitScript certified with 4.5-star Review.io rating
Cons
- −The $135 membership stacks on medication cost, so cash-pay semaglutide totals ~$286/mo, above average. The math works when you use the insurance coordination; cash payers should compare flat-rate platforms first.
- −Young company (founded 2023) with a relatively small review base and less track record than established platforms. Confirm the coordination promise against your own insurance plan before enrolling.
- −Prescription products are non-refundable once ordered, for any reason. Double-check dose and supply length before checkout.
Our Verdict
MEDVi edges out Zealthy with a score of 7.7/10 vs 7.2/10. If budget is your priority, MEDVi is $179/mo for the first month, then $299/mo compared to Zealthy at $286/mo for the first month, rises after. Choose MEDVi if you want: users who want a low entry price with oral and injectable compounded options. Choose Zealthy if you want: insured users who want dedicated coordinators handling prior authorizations for brand-name glp-1s (potentially $25/mo).
Cheapest in our index
Embody
$69/mo flat rate · 7.3/10 · Compounded
Both MEDVi and Zealthy start above the cheapest program we track. Across all 53 providers in our index, that floor is Embody at a flat $69/mo, the same rate at every dose, price checked July 31, 2026. It scores 7.3/10 and is not the highest-scored provider in our full rankings, so this is a cost floor rather than a recommendation. Worth knowing before you decide.
Read Full Reviews
Related comparisons
Other matchups readers comparing MEDVi or Zealthy tend to look at next.
- MEDVi vs Shed$199/mo
- MEDVi vs AgelessRx$199/mo
- MEDVi vs Hers$199/mo
- Zealthy vs Eden Health GLP-1$249/mo
- Zealthy vs bmiMD$289/mo
- Zealthy vs Found$129/mo
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.
Our pick of these two: MEDVi · 7.7/10